DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded by Bank of America to Buy Rating

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by Bank of America from a “neutral” rating to a “buy” rating in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has a $17.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $13.00. Bank of America‘s target price suggests a potential upside of 36.11% from the stock’s current price.

XRAY has been the topic of a number of other research reports. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Tuesday, December 16th. Barclays began coverage on shares of DENTSPLY SIRONA in a research note on Monday, December 8th. They set an “underweight” rating and a $12.00 price objective on the stock. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, February 3rd. Stifel Nicolaus set a $13.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, November 6th. Finally, Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Three investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $14.46.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $12.49 on Thursday. DENTSPLY SIRONA has a twelve month low of $9.85 and a twelve month high of $19.27. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36. The company has a market cap of $2.49 billion, a P/E ratio of -2.83, a price-to-earnings-growth ratio of 0.98 and a beta of 1.01. The business’s fifty day moving average is $12.20 and its 200-day moving average is $12.50.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the company’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its position in DENTSPLY SIRONA by 4.1% during the third quarter. Vanguard Group Inc. now owns 22,006,576 shares of the medical instruments supplier’s stock worth $279,263,000 after acquiring an additional 869,566 shares in the last quarter. First Eagle Investment Management LLC increased its stake in shares of DENTSPLY SIRONA by 3.2% during the 4th quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier’s stock worth $167,342,000 after purchasing an additional 458,744 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of DENTSPLY SIRONA by 109.8% in the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after purchasing an additional 6,970,086 shares during the period. Lazard Asset Management LLC lifted its stake in DENTSPLY SIRONA by 0.9% in the 3rd quarter. Lazard Asset Management LLC now owns 10,200,525 shares of the medical instruments supplier’s stock valued at $129,445,000 after purchasing an additional 92,868 shares during the last quarter. Finally, Armistice Capital LLC grew its holdings in DENTSPLY SIRONA by 27.2% during the fourth quarter. Armistice Capital LLC now owns 7,298,000 shares of the medical instruments supplier’s stock worth $83,416,000 after purchasing an additional 1,562,000 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.